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Background: The activity of transposable elements can be regulated by different means. DNA CpG methylation is
known to decrease or inhibit transpositional activity of diverse transposons. However, very surprisingly, it was
previously shown that CpG methylation of the Sleeping Beauty (SB) transposon significantly enhanced transposition
in mouse embryonic stem cells.
Results: In order to investigate the unexpected response of SB transposition to CpG methylation, related
transposons from the Tc1/mariner superfamily, that is, Tc1, Himar1, Hsmar1, Frog Prince (FP) and Minos were tested
to see how transposition was affected by CpG methylation. A significant increase of >20-fold in transposition of
SB, FP and Minos was seen, whereas Tc1, Himar1 and Hsmar1 showed no difference in transposition upon
CpG-methylation. The terminal inverted repeats (TIRs) of the SB, FP and Minos elements share a common
structure, in which each TIR contains two functionally important binding sites for the transposase (termed the
IR/DR structure). The group of IR/DR elements showed increased excision after CpG methylation compared to
untreated transposon donor plasmids. We found that de novo CpG methylation is not required for transposition.
A mutated FP donor plasmid with depleted CpG sites in both TIRs was as efficient in transposition as the wild-type
transposon, indicating that CpG sites inside the TIRs are not responsible for altered binding of factors potentially
modulating transposition. By using an in vivo one-hybrid DNA-binding assay in cultured human cells we found that
CpG methylation had no appreciable effect on the affinity of SB transposase to its binding sites. However,
chromatin immunoprecipitation indicated that CpG-methylated transposon donor plasmids are associated with a
condensed chromatin structure characterized by trimethylated histone H3K9. Finally, DNA compaction by
protamine was found to enhance SB transposition.
Conclusions: We have shown that DNA CpG methylation upregulates transposition of IR/DR elements in the Tc1/
mariner superfamily. CpG methylation provokes the formation of a tight chromatin structure at the transposon DNA,
likely aiding the formation of a catalytically active complex by facilitating synapsis of sites bound by the
transposase.Background
Co-evolution of transposable elements (TEs) with their
host species gave rise to several mechanisms that regulate
the transposition reaction [1], for example, cell or tissue
type [2,3], cell-cycle timing [4], transcriptional regulation
[5-7], posttranscriptional regulation by small RNAs [8-10],
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reproduction in any medium, provided the orDNA repair [12], and target site selectivity. The activity of
TEs can be regulated by chromatin at different stages of
the transpositional reaction. For example, the formation of
a catalytically active synaptic complex requires expression
of the transposase and a DNA topology that makes the
element accessible for the protein machinery required for
catalysis. The eukaryotic genome is typically organized into
either of two types of chromatin: euchromatin, a relatively
relaxed chromatin structure, in which the DNA is packed
less tightly and heterochromatin, a more inaccessible and
highly condensed fraction of the genome. HeterochromaticLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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them from euchromatic DNA, such as dense cytosine-
methylation (5-Me-C) of CpG sites, hypo-acetylation of
lysine residues in the N-terminal tails of histones H3 and
H4 and methylation of specific lysine residues such as
lysine 9 in histone H3. In contrast to euchromatin, which
is largely composed of unique (protein coding) sequences,
the DNA sequence of heterochromatin is usually repetitive
and gene poor [13]. One class of repetitive sequences
found in heterochromatic regions of different genomes are
TEs, and therefore it is believed that the accumulation of
transposable DNA sequences in heterochromatic regions
provides a safe place, where the deleterious potential of
these elements can be kept on a leash [14]. Indeed, there is
a strong correlation between chromatin structure and the
activity of TEs. For example, recruiting transposable DNAs
into heterochromatic regions may provide efficient silen-
cing of transcription of element-encoded proteins, and
thus provides genome stability. In addition to its repressive
function on transcription, heterochromatin also exerts a
repressive influence on recombination [15,16]; hence,
the containment of repeated sequences in heterochro-
matic regions may prevent irregular recombination
and genome instability.
CpG methylation is known to decrease or inhibit
transpositional activity of diverse transposons. However,
very surprisingly, Yusa et al. showed that CpG methylation
of the Sleeping Beauty (SB) transposon and to a smaller
extent the Tc3 element of Caenorhabditis elegans produced
elevated transpositional activity in mouse embryonic stem
(ES) cells [17]. Chromatin immunoprecipitation experi-
ments revealed that hyperactive genomic donor sites have
the characteristics of a heterochromatic structure. The SB
transposase was found to co-localize with heterochromatin
protein 1 (HP1), a well-established marker for heterochro-
matin, suggesting that the transposase preferentially associ-
ates with heterochromatic DNA [18]. Based on these
results, it was postulated that heterochromatin formation
at the transposon donor site can upregulate SB transpos-
ition [17].
We addressed the question whether transposition of
other Tc1/mariner elements is also enhanced by CpG
methylation. The elements of the Tc1/mariner superfam-
ily can be subdivided into two groups based on the size
and structure of their terminal inverted repeats (TIRs)
(Figure 1) [19]. The first group is characterized by short
TIRs (approximately 25 bp to 60 bp) containing a single
transposase binding site (TBS) per TIR, whereas the sec-
ond group has longer TIRs (>200 bp) harboring two
TBSs in the same orientation, which are thus referred to
as direct repeats (DRs). This arrangement is called the
IR/DR structure [19]. Here we extend the original obser-
vations on SB transposition by examining the effects of
CpG methylation on transposition of other Tc1/marinerelements. Transposition of six different transposons: SB,
Frog Prince (FP) [20], Minos [21], Tc1 [22], Himar1
[23] and Hsmar1 [24] was analyzed. We found that
the enhancing effect of CpG methylation is not re-
stricted to SB, but does not universally apply within
the Tc1/mariner family either. A shared feature of SB,
FP and Minos transposon TIRs is the IR/DR structure.
We propose a model where formation of a condensed
chromatin structure at transposon sequences is respon-
sible for the observed increase in transposition.
Results
Transpositional activities of different Tc1/mariner
elements upon CpG methylation
It was previously found that SB transposition is enhanced
by CpG methylation [17]. In order to extend these observa-
tions to other Tc1/mariner transposons, the effect of CpG
methylation on Tc1 and the Tc1-like elements FP and
Minos, and the mariner-like elements Himar1 and Hsmar1
was investigated. We generated transposon donor plasmids
containing the respective TIRs flanking a neomycin-
resistance gene trap cassette cloned into identical plasmid
backbones. Because CpG methylation would silence a
transgene promoter (thereby compromising the selection of
antibiotic-resistant cell colonies upon transposition), we
utilized a splice acceptor site upstream of the neomycin-
resistance gene, so that expression of the selectable marker
is dependent on transposition into an endogenous,
expressed gene. The donor plasmids were CpG-methylated
in vitro, and methylated or untreated donor plasmids were
co-transfected with the respective transposase-expressing
helper plasmids into cultured HeLa cells and selected with
G418. Confirming previous findings [17], transposition of
SB was enhanced >tenfold upon CpG methylation
(Figure 2). Varying degrees of enhancement of transpos-
ition were also seen for the FP and Minos elements; the
greatest increase in transposition, >30-fold, was seen for the
FP element (Figure 2). In contrast, transposition of Tc1,
Himar1 and Hsmar1 was not or only weakly affected by
CpG methylation (Figure 2). These data indicate that Tc1
family transposons of the IR/DR structure group are
responsive to CpG methylation.
CpG methylation does not affect binding of the Sleeping
Beauty transposase to transposon inverted repeats in vivo
Transposition is a multistep process consisting of: (i)
binding the transposase to the TIRs, (ii) synaptic complex
formation, (iii) transposon excision, (iv) target capture and
(v) transposon integration. Each of the studied IR/DR TEs
contains at least one CpG site in the TIRs (SB: 2, FP: 1,
Minos: 11). In order to address whether CpG methylation
affects binding of the SB transposase to its binding sites in
the TIRs, we applied a one-hybrid assay [25] to cultured
cells. The reporter plasmid contained a luciferase gene
Figure 2 Transposition activity of Tc1/mariner elements upon
CpG methylation. CpG-methylated (black bars) or untreated (grey)
Tc1-, Himar1-, Hsmar1-, Minos-, SB-, FP-gene trap donor plasmids
were co-transfected with/without transposase into HeLa cells and
selected with G418. The transposition ratio was calculated by
dividing the numbers of G418-resistant colonies obtained in the
presence of transposase by the number of colonies obtained in the
absence of transposase. Error bars are the standard deviation; the
asterisk indicates that the error bar cannot be displayed for FP
(±38.6). FP: Frog Prince; SB: Sleeping Beauty.
Figure 1 Structure of Tc1/mariner transposons. The transposons can be grouped by their different TIR structure. IR/DR TEs have long TIRs with
two transposase binding sites (TBSs) per TIR in the same orientation (direct repeats). Simple-structured TEs have short TIRs with only one TBS. Frog
Prince has 26 bp-long DRs, but the TBSs are only 21 bp. DR: direct repeat; ssTIR: simple-structured TIR; TBS: transposase binding site; TE:
transposable element; TIR: terminal inverted repeat; IR/DR: inverted repeat/direct repeat.
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binding sites upstream of the promoter. Untreated or
CpG-methylated reporter plasmids were co-transfected
with (i) the transcriptional activator plasmid expressing
N123-AD containing the N-terminal DNA-binding
domain of the SB transposase fused to a VP16-
transactivation domain that induces luciferase expression
upon TBS binding and (ii) a plasmid expressing full-length
SB transposase that binds TBS, but does not transactivate
luciferase expression, and thus acts as a competitor of
N123-AD. The activator induced luciferase expression
>350-fold, and co-expression of the competitor reduced
luciferase expression up to tenfold for both untreated and
CpG-methylated reporters (Additional file 1: Table S1).
CpG methylation of the reporter plasmid reduced luciferase
expression, presumably by promoter silencing (Figure 3).
However, the extent of reduction was always similar in the
presence or absence of the activator and the competitor
(Figure 3). We conclude that the SB transposase does
not have either reduced or enhanced affinity for
CpG-methylated DNA.
Methylation of CpG sites in transposon inverted repeats
is not required for enhanced transposition
Methylation of CpG sites in the transposon TIRs may
affect the affinity of DNA-binding proteins [26], for ex-
ample, it might increase binding of an enhancer or
Figure 3 In vivo binding of SB transposase. Untreated or CpG-methylated p5SB-luc reporter plasmids were co-transfected with/without the
activator plasmid pc-SB(123)-AD and with/without a full-length SB transposase competitor into HeLa cells. After 48 h luciferase expression was
determined. To compare the effect of CpG methylation, ratios were calculated by dividing the value for luciferase expression with untreated
donor plasmids by the value for luciferase expression with CpG-methylated donors. Three independent experiments are shown. No statistically
significant differences were obtained.
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enhancing transposition. Both SB and Minos contain
CpG sites in their TBSs and, therefore, mutagenesis of
the TBS sequence is expected to drastically affect or
abolish transposase binding. However, FP has only one
CpG site in its TIRs outside the TBSs (plus 435 additional
CpG sites distributed all across the rest of the plasmid).
We mutated the CpG site at both TIRs of FP to a CpA
sequence that cannot be methylated, and compared the
transpositional activity of the mutant transposon to the
wild-type transposon in the absence and presence of CpG
methylation. No differences in transposition were detected
either for untreated or for CpG-methylated donor
plasmids (Figure 4). We conclude that it is not a particu-
lar CpG site inside the TIRs, but rather the global CpG
content of the transposon plasmid that is responsible for
the observed enhancing effect of CpG methylation.
CpG methylation enhances Sleeping Beauty transposon
excision in vivo
In order to identify the step(s) at which CpG methylation
influences transposition, we subjected the six elements to
a PCR-based excision assay. CpG-methylated or untreated
donor plasmids were co-transfected with the respective
helper plasmids into cultured HeLa cells and were re-
isolated 48 h post-transfection. Amplification of trans-
poson excision sites of the donor plasmids via nested PCR
produces a 308-bp-long amplicon, whose band intensity
in gel electrophoresis was used as measure of transposon
excision. Consistent with the effect on transposition, exci-
sion of IR/DR-elements SB, FP and Minos was enhanced
by CpG methylation (Figure 5A). By serial dilution of PCR
input DNA, we quantified the increase of excision ef-
ficiency for FP, which is enhanced at least 16-fold by
CpG methylation. This is in accordance with the 20-fold
increase in overall transposition upon CpG methylationobtained in the colony-based assay. Again, the group of
simple-structured TIR (ssTIR) elements showed no
increase in excision activity; in contrast, excision was
significantly lower or even undetectable following CpG
methylation. Thus, the enhancing effect of CpG methyla-
tion on transposon excision is limited to the elements of
the IR/DR group.
Transiently transfected plasmids can become CpG-
methylated in the cell de novo [27]. CpG methylation in
mammals is catalyzed by three DNA-methyltransferases
(Dnmts): Dnmt1 is responsible for the maintenance of
CpG methylation patterns, and Dnmt3a and Dnmt3b
perform de novo CpG methylation. We tested the exci-
sion activity of untreated and CpG-methylated SB trans-
poson donors in HCT116 knockout/knockdown cell
lines lacking either Dnmt1 or Dnmt3b or both [28,29]
by PCR-based excision assay (Figure 5B). All cell lines
supported transposon excision. However, in these cells
Dnmt3a is still active and could provide de novo CpG
methylation of transfected donor plasmids. Thus, to in-
hibit the activity of Dnmt3a, we used the chemical aza-
deoxycytidine, which is a known inhibitor of cellular de
novo CpG methylation. Aza-deoxycytidine was added to
cultured, HCT116-derived Dnmt3b knockout cells in a
range of 1 μM to 1 mM two days prior to co-
transfection of the transposon plasmids. The PCR-based
excision assay (Figure 5C) showed that transposon exci-
sion is still detectable at high concentrations of aza-
deoxycytidine. Even though PCR band intensity became
weaker at increasing aza-deoxycytidine concentrations,
this is likely due to the cytotoxic effects of aza-
deoxycytidine, which is accompanied by reduced cell sur-
vival and cell growth. The enhancing effect of in vitro CpG
methylation was not affected by aza-deoxycytidine treat-
ment. We conclude that host-mediated de novo CpG
methylation is not required for transposition.
Figure 4 Transposition of CpG-free FP TIRs. (A) CpG sites inside the FP TIRs were mutated to obtain pFPΔCpG-GTC. (B) Transposition assay of
CpG-methylated or untreated pFPΔCpG-GTC and pFP-GTC was performed in HeLa cells in the presence or absence of transposase. FP: Frog Prince;
TIR: terminal inverted repeat.
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condensed chromatin
As CpG methylation did not seem to have a direct
influence on transposition, we hypothesized that it
affects the transposition process indirectly, by inducing het-
erochromatin formation and persistence. Indeed, genomic,Figure 5 Excision activity upon CpG methylation. CpG-methylated or u
plasmid; 48 h post-transfection plasmids were extracted, purified and DNA
product band intensity represents the relative efficiency of transposon exci
Dilutions of PCR input DNA for quantification of FP excision. (B) Excision of
Dnmt3b knockout cells. Increasing amounts of aza-deoxycytidine (aza-dC) b
Prince; SB: Sleeping Beauty; PCR: polymerase chain reaction; TE: transposableCpG-methylated transposons were shown to be associated
with heterochromatin [17]. We utilized a chromatin immu-
noprecipitation (ChIP) assay to investigate chromatin struc-
ture on transposon donor plasmids. CpG-methylated and
non-methylated pFP-GTC donor plasmids were transfected
into HeLa cells, cross-linked and immunoprecipitated usingntreated donor plasmids were co-transfected with/without a helper
amounts were normalized. After two rounds of nested PCR, the
sion. (A) Excision activity of different TEs in HeLa cells. Upper panel:
SB in different HCT116 knockout cell lines. (C) SB excision in HCT116
lock de novo CpG methylation. aza-dC: aza-deoxycytidine; FP: Frog
element.
Jursch et al. Mobile DNA 2013, 4:15 Page 6 of 11
http://www.mobilednajournal.com/content/4/1/15antibodies against acetylated histone H3 (a marker for open
chromatin) or against trimethylated H3K9 (a marker for
condensed heterochromatin). The co-precipitated DNA
was purified and analyzed by (i) semi-quantitative PCR and
(ii) transformation of recovered donor plasmids into
Escherichia coli and subsequent colony counting (Figure 6).
As quantified by bacterial transformation, anti-acetylated
histone H3 (anti-AcH3) antibodies precipitated threefold
less CpG-methylated transposon plasmids than non-
methylated transposon plasmids, suggesting an enrichment
of non-methylated plasmids in open chromatin (Figure 6A).
Conversely, immunoprecipitation with anti-trimethylated
histone H3 lysine 9 (anti-H3triMeK9) antibodies resulted in
reduced recovery of non-methylated plasmids compared to
CpG-methylated plasmids, implying an enrichment of
condensed chromatin status for CpG-methylated plasmids.Figure 6 CpG-methylated transposon plasmids are associated
with condensed chromatin. CpG-methylated or untreated pFP-GTC
donor plasmids were transfected into HeLa cells, cross-linked, and
precipitated with anti-acetylated histone H3 (anti-AcH3) antibodies
indicating euchromatin or anti-trimethylated histone H3 lysine
9 (anti-H3triMeK9) antibodies indicating heterochromatin. DNA
was purified and quantified by E. coli transformation (A) or by
semi-quantitative PCR after serial dilutions of input DNA (B). anti-AcH3:
anti-acetylated histone H3; anti-H3triMeK9: anti-trimethylated histone
H3 lysine 9; PCR: polymerase chain reaction.PCR analyses of the immunoprecipitated DNA samples
showed, in accordance with the results obtained by bacter-
ial transformation, a relative enrichment of non-methylated
plasmids in the euchromatic fraction (precipitation
with anti-AcH3 antibody) and a relative enrichment
of methylated plasmids in the heterochromatic fraction
(precipitation with anti-H3triMeK9 antibody) (Figure 6B).
We conclude that CpG-methylated plasmids are associated
with condensed chromatin.
Precomplexing transposon DNA with protamine enhances
Sleeping Beauty transposition
To test if DNA condensation is an underlying structural
determinant of enhanced transposition in our experiments,
we sought to examine the effect of condensation intro-
duced into transposon DNA by means other than CpG
methylation. We opted to package and condense trans-
poson donor plasmids using protamine. Protamines are
small, basic, arginine-rich peptides that largely replace
histones in sperm chromatin, and package DNA into the
most condensed eukaryotic DNA known [30].
Antibiotic-resistance-gene-containing SB transposon
donor plasmids were pre-incubated with protamine, and
transfected into human HeLa cells expressing SB
transposase, followed by antibiotic selection and counting
of resistant cell colonies. Pre-incubation of SB transposons
with protamine resulted in an approximately threefold
enhancement of transposition compared to uncondensed
plasmids (Figure 7). The enhancing effect of protam-
ine on stable gene transfer was only manifested with
transposition-competent vectors; treatment of transpo-
sitionally incompetent vectors with protamine appar-
ently had no effect on colony numbers (Figure 7). We
conclude that condensation of transposon DNA has
an enhancing effect on SB transposition.
Discussion
The original finding that CpG methylation enhances
Sleeping Beauty transposition [17] was very surprising,
as CpG methylation has been known to play a crucial role
in the cellular defense against TEs. We now extend these
observations to other members of the Tc1/mariner super-
family, and show that this phenomenon is not restricted to
SB, but seems to be an intrinsic feature associated with the
characteristic IR/DR structure of the SB, Frog Prince and
Minos elements (Figure 2).
We tested several hypotheses that provided possible
explanations for the enhancing effect of CpG methylation
on transposition. It is formally possible that CpG methyla-
tion is a prerequisite for transposition of SB, FP and Minos.
In this case donor plasmids that are CpG-methylated
in vitro would have a head start against non-methylated
donors, which would need to be methylated by cellular
factors following transfection. We tested transposition of
Figure 7 Protamine enhances SB transposition. Transpositionally
competent as well as incompetent (negative control) SB transposon
plasmids were precomplexed with protamine in vitro, followed by
transfection into transgenic HeLa cells stably expressing the SB
transposase. The transfected cells have undergone antibiotic selection
to allow a quantitative measurement of transposition efficiencies
represented by antibiotic-resistant colony numbers. SB: Sleeping Beauty.
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Dnmt3b knockout/knockdown cell lines and in the
presence of aza-deoxycytidine, which blocks de novo
CpG methylation. Transposition was as efficient under
these conditions as in wild-type or untreated cells
(Figure 5), thus we conclude that CpG methylation is not
required for transposition.
An alternative hypothesis predicts that one (or several)
particular CpG sites inside the TIRs might affect CpG
methylation. An enhancer of transposition might possibly
be attracted by methylated CpG sites or, alternatively, a
potential repressor might be distracted. However, a
mutated FP donor plasmid with depleted CpG sites in
both TIRs was as efficient in transposition as the wild-type
transposon (Figure 4). Thus, CpG sites inside the TIRs do
not seem to be responsible for the binding of any
transposition-enhancing factor or the blocking of any
transposition repressor.
Binding of the SB, FP and Minos transposases might
directly be supported by CpG sites inside the TBSs, the
TIRs or close to them. Alternatively, CpG methylation
could increase transposition indirectly; for example by
the formation of heterochromatin following binding of
methylated CpG sites by the HP1 or MeCP2 (a proteinthat binds specifically to methylated DNA) proteins
[31,32]. Yusa et al. [17] tested SB transposase binding to
TBSs in vitro and did not detect any influence from CpG
methylation. In line with these previous observations, the
expression of luciferase as a reporter for TBS binding in an
in vivo one-hybrid assay was affected by CpG methylation
to the same extent in all background controls, binding
experiments and under competition conditions (Figure 3).
We thus conclude that CpG methylation had neither a
direct nor an indirect effect on SB transposase binding.
Our findings suggest an indirect effect of CpG methy-
lation on transposition rather than a direct influence.
Because (i) enhancement of CpG methylation is detectable
at the transposon excision step (Figure 5), (ii) CpG methyla-
tion was found to induce the formation of a condensed
chromatin structure (heterochromatin) (Figure 6), and (iii)
DNA compaction by protamine was found to enhance
transposition (Figure 7), we propose a model, in which
CpG methylation and subsequent chromatin condensation
aids synaptic complex formation. Indeed, transposition
critically depends on the formation of a synaptic complex
that is built up of the transposon TIRs, transposase proteins
and additional, host-encoded proteins. It is formally
possible that CpG methylation-induced chromatin conden-
sation brings the TIRs closer together, thereby promoting
synaptic complex assembly. However, our studies on sev-
eral, closely related Tc1/mariner-elements revealed the
selective importance of TIR structure for the observed
sensitivity for CpG methylation. Namely, only the SB, FP
and Minos elements were responsive to CpG methylation;
these IR/DR elements share a common structure of two
TBSs per TIR (Figure 1). Heterochromatin formation
results in tight packaging of DNA and histones. As a result,
DNA sites that are usually far away from each other;
for example, the two TBSs inside one TIR, might be
brought closer together (Figure 8). The physical
proximity of the inner and outer TBSs might assist
the formation of transposase dimers as soon as they
bind, thereby facilitating the formation of a catalytically
active synaptic complex.
Conclusions
CpG methylation/heterochromatin is one of the regulatory
mechanisms that silence and inhibit TE activity. The
potential of TEs to escape a regulatory mechanism
imposed by the host is a strong evolutionary advantage (at
least for the transposon). Assuming that the transposase
source is provided by a transcriptionally active element lo-
cated in euchromatin, host-cell induced CpG methylation/
heterochromatin-based silencing of TEs can be offset by
higher transposition efficiency out of condensed chroma-
tin, thereby constituting a potential mechanism for SB and
other, similar-structured transposons to escape CpG
methylation-mediated silencing.
Figure 8 A model of a molecular mechanism of enhanced synaptic complex assembly by condensed DNA packed into
heterochromatin. CpG methylation induces heterochromatin condensation whereby the TBSs inside the TIRs will come into close proximity.
Hence, the formation of transposase dimers is improved, which subsequently enhances the formation of synaptic complexes. TBS: transposase
binding site; TIR: terminal inverted repeat.
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Plasmid construction
A 200 bp-minivariant of Himar1 (GenBank #U11644)
was amplified out of pMM2611 [33] via PCR using the
primer Himar1/IR (TAACAGGTTGGCTGATAAGT
CCCC). A 1.6 kb fragment of Tc1 (GenBank #X01005)
was amplified out of pTc1_Ex/01 with primer Tc1/IR
(TACAGTGCTGGCCAAAAAGATATCC). The PCR
products were purified, phosphorylated and ligated into
a SmaI digested, dephosphorylated vector pUC19. After
transformation in E. coli DH10B cells, plasmids were
isolated, test digested and sequenced. pUC19-Himar1
was SmaI digested, pUC19-Tc1 was StyI digested;
both were dephosphorylated and ligated with the
Klenow-treated gene trap cassette (GTC) (HindIII-
NotI-XmnI digest of plasmid Δ170_CMV_zeo#1)
[20]. After transformation in E. coli DH10B,
plasmids were prepared and control digested to
verify the expected plasmid layout. For Minos
(GenBank #X61695) the plasmid pMiLRneo [34] was
HindIII-NotI digested and ligated with the formerly
described HindIII-NotI fragment of the GTC. TheTIRs harboring the GTC were amplified out using
PCR primer Minos/IR (TACGAGCCCCAACCACT
ATTAATTC). The PCR product was purified and
ligated into SmaI digested pUC19. The product was
checked by test digestion and sequencing. pSB-GTC
(= GT/neo_CMV/zeo #2), derived from pT/neo [35],
pFP-GTC (= pFP/GT-neo) [20] and pHsMar1-GTC
and pHsmar1-GTCrev [24] were provided by C
Miskey. The plasmids containing the transposases
have been previously published: Tc1: pCMV/Tc1 [36],
Himar1: pCMV/Himar3x [36], pSB10: [35], Minos:
pJGD/ILMi [37], FP: pFV-FP [20], Hsmar1: pHsmar1
[24]. pFPΔCpG-GTC: FP TIRs on plasmid pFP-GTC
were mutated using the Stratagene QuikChange
Multi Site Directed Mutagenesis Kit following the
manufacturer’s instructions with phosphorylated
primers FP/IR_CpG_delete_syn (P-TGTTTGTCACA
CTTAA-GTGTTTCAGAACATCAAA-CCAATTTAAA
CAATAG) and FP/IR_CpG_delete_anti (P-CTATTGT
TTAAATTGGTTTGATGTTCTGAAACA-CTTAAGT
GTGACAAACA). The mutated plasmid pFPΔCpG-
GTC was transformed in QuikChange XL1-Blue
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sequenced.
In vitro CpG methylation
Donor plasmids were CpG-methylated by SssI CpG methyl-
ase (NEB), and purified with the Qiagen PCR purification
kit. Complete methylation was tested by control digests
using methylation-sensitive restriction enzymes NotI
(pMiLRgeo) or SalI (all others), and compared to a control
digest of the respective untreated donor plasmids.
Cell culture, transfections and DNA condensation by
protamine
HeLa cells were cultured in DMEM with 4.5 g/L glucose
and 110 mg/L pyruvate supplemented with 10% fetal calf
serum (FCS) and an antibiotic/antimycotic cocktail
(DMEM+/+) at 37°C. Cells were passaged via
trypsinization with 1:5 dilution of 0.5% trypsin in 5.3 mM
ethylenediaminetetraacetic acid (EDTA). Transfections
were done at 60% to 80% cell confluency in DMEM with-
out antibiotics (DMEM+/−) with the Fugene6 transfection
reagent (Roche). For transposition assays, 6 × 105 cells
were transfected with CpG-methylated or untreated donor
plasmids (500 ng) together with transposase expression
plasmids (50 ng). Complexing with protamine sulfate was
done as described previously [38] by pre-incubating
500 ng plasmid DNA with 1 μg protamine sulfate
(Sigma-Aldrich) for 15 min at room temperature,
followed by the addition of Fugene6 as described above.
Excision PCR
Cells (6 × 105) were transfected with equal amounts of
CpG-methylated or untreated donor plasmids plus equal
amounts of transposase-carrying helper or control
plasmids. Typically 250 ng or 500 ng of donor plasmid was
used and 50 ng of helper plasmid. Two days after transfec-
tion, the cells were harvested, plasmid DNA was prepared
with the Qiagen Miniprep kit in a volume of 50 μL. A 1:10
dilution of 1 μL of the extracted DNA served as template
for input normalization PCR utilizing primers Amp-For
(TGCACGAGTGGGTTACATCGAACT) and Amp-Rev
(TTGTTGCCATTGCTACAGGCATCG). Normalized
DNA amounts served as templates for nested PCR utilizing
pUC2 (GCGAAAGGGGGATGTGCTGCAAGG) and
pUC5 (TCTTTCCTGCGTTATCCCCTGATTC) in the
first, and pUC19-3F (GTTTTCCCAGTCACGACGTT)
and pUC19-3R (TGTGGAATTGTGAGCGGATA) in the
second PCR. PCR protocol: 95°C 3 min, 30 cycles of 95°C
30 s, 58°C 20 s, 64°C 10 s, and 72°C 2 min. The PCR
products were subjected to gel electrophoresis.
Chemical block of CpG methylation
Two days prior to transfection cells were treated with
different amounts of 5-aza-2′-deoxycytidine (aza-dC),ranging from 1 μM to 1 mM. Aza-dC addition was
repeated daily after previous medium exchange. Then,
6 h before transfection, aza-dC was removed from the
cells and added again 6 h post-transfection.
One-hybrid assay
HeLa cells (6 × 105) were transfected with 300 ng CpG-
methylated or untreated p5SB-luc reporter plasmid, 90
ng pc-SB(123)-AD activator plasmid [25] and 1.1 μg
pCMV-SB10 competitor plasmid (or filled with adequate
control plasmids). Two days later, transfected cells were
washed, treated with CCLR buffer (5× buffer: 125 mM
Tris*H3PO4 pH 7.8, 10 mM dithiothreitol (DTT), 10
mM 1,2 cyclohexane-diaminetetra-acetic acid (CDTA),
50% glycerol, 5% Triton X-100), incubated for 15 min on
ice and vortexed for 15 s. Cell debris was pelleted for 2
min with 12,000g at 4°C. 30 μL of the supernatant was
combined with 100 μL luciferase buffer (20 mM tricine-
NaOH pH7.8, 1.07 mM Mg(CO3)4 Mg(OH)2*5H2O, 2.67
mM MgSO4, 0.1 mM EDTA, 470 μM luciferin, 530 μM
ATP, 33.3 mM DTT), vortexed briefly and measured in
the luminometer.
Chromatin immunoprecipitation
Cells (4×106) were transfected in either four 5-cm or
one 10-cm culture dish with approximately 3 μg CpG-
methylated or non-methylated pFP-GTC donor plasmid.
24 h after incubation, 37% formaldehyde was added to
the medium to an end concentration of 1%. The culture
dishes were put into a plastic bag, sealed and incubated
for 10 min at 37°C. After removal of the medium and
two washing steps with ice-cold PBS containing protease
inhibitors (1 mM PMSF, 1 μg/mL aprotinin, 1 μg/mL
pepstatin A), the cells were scraped, transferred into 1.5
mL Eppendorf tubes and centrifuged for 4 min at 4°C at
2,000g. The pellet was resuspended in 400 μL lysis buffer
[1% sodium dodecyl sulfate (SDS), 10 mM EDTA, 50
mM Tris–HCl pH 8.1, protease inhibitors]. Each sample
was split into 2× 200 μL samples, incubated for 10 min
on ice and centrifuged for 10 min at 4°C at 13,000 rpm.
Supernatants were transferred to fresh 2 ml Eppendorf
tubes and 1,800 μL ChIP dilution buffer (0.01% SDS,
1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris–HCl
pH 8.1, 167 mM NaCl, protease inhibitors) and 80 μL
salmon sperm DNA/Protein A agarose-50% slurry (0.2
mg/mL sonicated salmon sperm DNA, 0.5 mg/mL BSA,
approximately 1.5 mg/mL recombinant Protein A, 0.05%
sodium azide) were added. The Eppendorf tubes were
incubated for 30 min on a rotating plate at 4°C. The
agarose was pelleted using brief centrifugation and the
supernatants were transferred to new tubes. Polyclonal
antibodies anti-acetylated histone H3 (anti-AcH3)
(provided with the ChIP Kit, Upstate #06-599, Lot 27610)
or anti-trimethylated histone H3 lysine 9 (anti-H3triMeK9)
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10 μL) and incubated overnight at 4°C on a rotating plate.
The next day, 60 μL of salmon sperm DNA/Protein A
agarose-50% slurry was added and incubated for 1 h at 4°C
with rotation. The agarose was pelleted at 900 rpm for 1
min at 4°C and washed with low salt immune complex
wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20
mM Tris–HCl pH 8.1, 150 mM NaCl), high salt immune
complex wash buffer (0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris–HCl pH 8.1, 500 mM NaCl), LiCl
immune complex wash buffer [0.25 M LiCl, 1% Nonidet
P-40 (NP40), 1% deoxycholate, 1 mM EDTA, pH 8.0] and
twice with TE buffer (10 mM Tris–HCl, 1 mM EDTA, pH
8.0). The chromatin was eluted by the repeated addition
of 250 μL elution buffer (1% SDS, 0.1 M NaHCO3) to the
pellet, vortexing and 15 min incubation followed by
pelleting the agarose and saving the supernatant in a fresh
1.5 mL tube. To the combined (500 μL) eluates, 20 μL 5
M NaCl was added and heated for 4 h at 65°C to reverse
cross-linking (samples were stored at this point overnight
at −20°C). Using 10 μL 0.5 M EDTA, 20 μL 1 M Tris–HCl
pH 6.5 and 2 μL proteinase K, histones and other DNA-
bound proteins were digested for 1 h at 45°C. The
remaining residues were extracted twice with phenol/
chloroform and the DNA was precipitated with isopropanol
(standard protocol). The DNA was taken up in H2O and
re-purified by dialysis. For the quantification of plas-
mids, the extracted DNA was either transformed into
electrocompetent E. coli DH10B or used in a semi-
quantitative PCR (primer Amp-For and Amp-Rev).
Transformed cells were plated on ampicillin/zeocin/
LB (Luria-Bertani) agar and incubated overnight at
37°C. Colonies were counted the next morning.Additional file
Additional file 1: Table S1. One-hybrid assay reads. Reporter, activator
and competitor plasmids were co‐transfected into HeLa cells. Cells were
harvested 48 h post‐transfection, and protein extracts were used in
luciferase assays. Three repetitions are shown.Abbreviations
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